Our probiotic powder inhibited Treg cell activity, increased the abundance of IFN-γ+ CD8+ T cells, CD4+ IL-4+ Th2 cells and CD19+ GL-7+ B cells in the immune microenvironment of CRC. The gene discussed is CD19; the disease is colorectal carcinoma.